PATENT CLAIM ANALYSIS

Application Number: 16087947
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["546", "053000"]

Abstract:
The present invention provides a medicament useful for treatment and/or prevention of cancer, a vaccine adjuvant, and an inhibitor of immune checkpoint comprising a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein Bonds a-d, Ring A, R 1 , R 1′ , R 2 , R 2′ , R 3 -R 8 , and n are as defined in the present specification.

Claim (Index 9):
The compound of  claim 1  or a pharmaceutically acceptable salt thereof, wherein R 5 , R 6 , and R 7  are independently hydrogen or hydroxy.

Metadata:
- Claim Count in Document: 36.0
- Percentile: 97.0
- Lexical Diversity: 1.37037
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15766985', '14238507', '10932463', '11587906', '15799771']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7745287528326966
- 35 USC 102 Novelty (BERT): 0.5284428890492553
- Combined Prediction Score: 0.7499201664543526
- Mean Citation Score: 319.059382
- Max Citation Score: 326.9722
- Similarity Product: 217.40765671548843

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test